Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Amgen drops on Novartis trial setback for heart therapy; BMO downgrades

We haven't written up this one. Seeking Alpha News has the full story — the link below goes straight to it.

This story

This is one outlet's version. Read the fullest account.

Read the original at seekingalpha.com →

More in Finance & Markets

More from Tuesday 8 September →